Scarica l'app Stockscreener
50.02
4.19%
2.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$48.01
Aprire:
$48.96
Volume 24 ore:
223.20K
Relative Volume:
0.53
Capitalizzazione di mercato:
$1.62B
Reddito:
-
Utile/perdita netta:
$-91.00M
Rapporto P/E:
-13.63
EPS:
-3.67
Flusso di cassa netto:
$-74.38M
1 W Prestazione:
+7.16%
1M Prestazione:
+17.49%
6M Prestazione:
-22.83%
1 anno Prestazione:
+37.19%
Intervallo 1D:
$48.49
$50.15
Intervallo di 1 settimana:
$46.03
$50.15
Portata 52W:
$30.82
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Confronta IRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
50.02 | 1.62B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Ameriprise Financial Inc. Invests $335,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Bank of America Corp DE Reduces Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of “Buy” from Analysts - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Nuveen Asset Management LLC - Defense World
Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire
Disc Medicine Sets Double Conference Appearance: Jefferies and Goldman Sachs Healthcare Events - Stock Titan
BNP Paribas Financial Markets Invests $324,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Stock Position Raised by Deutsche Bank AG - Defense World
Medical Marijuana (OTCMKTS:MJNA) Stock Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Disc Medicine Shows Improved Relative Price Performance; Still Shy Of Benchmark - MSN
Insider Sell: William Savage Sells Shares of Disc Medicine Inc (IRON) - GuruFocus
Disc Medicine’s chief medical officer sells $334,128 in stock By Investing.com - Investing.com Canada
Disc Medicine’s chief medical officer sells $334,128 in stock - Investing.com
Porphyria Pipeline 2025: Groundbreaking Clinical - openPR.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Northern Trust Corp - Defense World
Commit To Buy Disc Medicine At $35, Earn 14.1% Annualized Using Options - Nasdaq
Disc Medicine Announces Multiple Presentations Across Portfolio - GuruFocus
Disc Medicine, Inc. to Present Key Data from Hematology Portfolio at EHA 2025 Congress - Nasdaq
Disc Medicine Announces Multiple Presentations Across - GlobeNewswire
Disc Medicine Reveals First Disease-Modifying EPP Treatment Data Among 6 Clinical Updates at EHA 2025 - Stock Titan
BMO Capital Markets Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - Defense World
Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference - The Manila Times
Tower Research Capital LLC TRC Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
How To Trade (IRON) - news.stocktradersdaily.com
Disc Medicine (IRON) Price Target Raised by BMO Capital | IRON S - GuruFocus
Promising Outlook for Disc Medicine’s DISC-0974 in Anemia Treatment Justifies Buy Rating - TipRanks
BMO Capital Boosts Price Target for Disc Medicine (IRON) to $120 - GuruFocus
Cantor Fitzgerald Comments on Disc Medicine FY2025 Earnings - Defense World
Q2 EPS Estimates for Disc Medicine Cut by Leerink Partnrs - Defense World
Insider Sellers Might Regret Selling Disc Medicine Shares at a Lower Price Than Current Market Value - simplywall.st
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by Dimensional Fund Advisors LP - Defense World
Wedbush Issues Negative Forecast for Disc Medicine Earnings - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Disc Medicine Reports Strong Q1 2025 Progress - TipRanks
Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation - Yahoo Finance
Decoding Disc Medicine Inc (IRON): A Strategic SWOT Insight - GuruFocus
Market Resilience: Disc Medicine Inc (IRON) Finishes Weak at 42.58, Down -12.40 - DWinneX
Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Disc Medicine reports Q1 EPS ($1.02), consensus ($1.07) - TipRanks
Disc Medicine, Inc. SEC 10-Q Report - TradingView
Disc Medicine Inc (IRON) Reports Q1 2025 EPS of -$1.02, Aligns with Estimates; Strong Cash Position of $694.7 Million - GuruFocus
Disc's Bitopertin Program Advances with APOLLO Trial Launch | IRON Stock News - GuruFocus
Disc Medicine, Inc. Reports Q1 2025 Financial Results and Updates on Bitopertin and Pipeline Programs - Nasdaq
Invesco Ltd. Increases Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
(IRON) On The My Stocks Page - news.stocktradersdaily.com
Wells Fargo & Company MN Grows Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF) - The Manila Times
Leading Cancer Centers Join Forces to Review Breakthrough Myelofibrosis Anemia Treatment Data - Stock Titan
JPMorgan Chase & Co. Purchases 44,762 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Renaissance Technologies LLC Makes New $5.48 Million Investment in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Disc Medicine Inc Azioni (IRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Savage William Jacob | Chief Medical Officer |
May 20 '25 |
Sale |
50.04 |
6,677 |
334,128 |
59,721 |
| Savage William Jacob | Chief Medical Officer |
May 02 '25 |
Sale |
50.17 |
2,100 |
105,367 |
66,398 |
1.21%
1.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):